Publications by authors named "L Vold"
Objectives: We analysed hepatitis A (HepA) notifications and hospitalisations in Italy, the Netherlands, Norway, Spain, and Sweden for available periods between 1995 and 2014. We aimed to investigate whether decreasing HepA incidence is associated with increasing age at infection and worsening HepA presentation and to identify groups at risk of severe disease.
Methods: We performed a retrospective cohort study including 36 734 notified and 36 849 hospitalised patients.
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Euro Surveill
January 2022
We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from December 2021 to January 2022. We estimated a 73% reduced risk of hospitalisation (adjusted hazard ratio: 0.27; 95% confidence interval: 0.
View Article and Find Full Text PDFIn late November 2021, an outbreak of Omicron SARS-CoV-2 following a Christmas party with 117 attendees was detected in Oslo, Norway. We observed an attack rate of 74% and most cases developed symptoms. As at 13 December, none have been hospitalised.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to compare the hospitalization risk of the Delta and Alpha variants of COVID-19 in Norway, focusing on vaccination status.
- Researchers analyzed 19,055 lab-confirmed cases of SARS-CoV-2 from May to August 2021, finding similar hospitalization risks for both variants.
- The study concluded that vaccination significantly reduces hospitalization risk, with partially vaccinated individuals having a 72% reduced risk and fully vaccinated individuals having a 76% reduced risk compared to unvaccinated cases.